Philip Astley-Sparke, a director at Replimune Group, Inc. ($REPL), made one open market sale of common shares in the last 365 days, totaling $260,169. His most recent sale occurred on May 20, 2025. These sales rank 7,863rd among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across about 6 transactions per insider. Astley-Sparke had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Replimune Group, Inc. | $REPL | Astley-Sparke Philip | Director | G | Common Stock | 25000 | $0.00 | 1,380,071.0000 | 92,187,581 | 1.78% | 0.03% |
| July 8, 2025 | enGene Holdings Inc. | $ENGN | Astley-Sparke Philip | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2025 | Replimune Group, Inc. | $REPL | Astley-Sparke Philip | Director | S | Common Stock | 32279 | $8.06 | 1,405,071.0000 | 80,564,147 | 2.25% | 0.04% |
| Aug. 30, 2024 | Replimune Group, Inc. | $REPL | Astley-Sparke Philip | Executive Chairman | G | Common Stock | 50000 | $0.00 | 1,437,350.0000 | 66,569,894 | 3.36% | 0.08% |
| May 16, 2024 | Replimune Group, Inc. | $REPL | Astley-Sparke Philip | Executive Chairman | S | Common Stock | 37928 | $6.47 | 1,487,350.0000 | 66,569,894 | 2.49% | 0.06% |